Objective: To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF ... Uncertainties over the optimal treatment for elderly patients with AF still ...

And the odds go up as you get older. If your heart races rather ... Heart rate control is a key way to manage atrial fibrillation. Doctors consider it one of the four pillars of AFib care.

Additionally, older age was associated with higher incidence of atrial fibrillation ... the recommended initial treatment of patients at risk for AF (stages 1 or 2) or with AF (stages 3 or ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it. Whenever he’d overexert himself, he’d feel “different,” but it would go away with rest.

Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the ...

Queen Sonja of Norway was admitted to the hospital on Jan. 11 following a flare-up of her atrial fibrillation while skiing.

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...

The Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention ... An INR goal of 2.0-3.0 should be the standard of practice for elderly patients with AF when warfarin is indicated.

“The older you are, the incidence of atrial fibrillation continues ... Right now, there’s no cure for atrial fibrillation, and experts in the field say treatment is not always necessary ...

Atrial fibrillation is the most common chronic arrhythmia ... Lower ventricular response rates in unmedicated older patients suggest underlying conducting system disease. [Kawaji T, et al.